CAVA Group, Inc. CAVA 深 滬
等待開盤 06-25 09:30:00 美东时间
82.24
+4.670
+6.02%
華盛通- 最 高82.30
- 今 開77.56
- 成交量 244.75万股
- 最 低 76.78
- 昨 收 77.57
- 總市值 95.79亿
- 52周最高 98.79
- 市盈率 靜 152.61
- 換手率 2.10%
- 52周最低 43.41
- 委 比 98.02%
- 總股本 1.16亿
- 歷史最高 172.4299
- 量 比 0.77
- 振 幅 7.12%
- 歷史最低 29.05
- 每 手 1
- 風險率 13.26%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Jim Cramer Calls CAVA 'Tasty, Clean, Fun,' Says Make This Biotech 'Your Speculation'
On CNBC's “Mad Money Lightning Round,” Jim Cramer recommended buying CAVA Group, Inc. (NYSE:CAVA). “I think it's the best of the new concepts. I think there's something there for everybody. There really is. It's tasty, clean, fun,” he added. Supporting his view, UBS analyst Dennis Geiger, on June 10...
06-17 19:50
美股大行评级 | 高盛上调美光科技目标价从400美元升至900美元；斯马克、Cloudflare获多家公司上调目标价
今日重点评级关注：Ascendiant Capital：维持NextTrip"买入"评级，目标价从7美元升至7.5美元；Maxim Group：维持Zevra Therapeutics"买入"评级，目标价从25美元升至35美元
06-11 09:55
UBS Upgrades Cava Group to Buy, Raises Price Target to $90
UBS analyst Dennis Geiger upgrades Cava Group (NYSE:CAVA) from Neutral to Buy and raises the price target from $85 to $90.
06-10 21:10
CAVA Stock Edges Higher Friday: What's Driving The Action?
CAVA Group (NYSE: CAVA) shares are trading higher Friday as investors keep leaning into its upbeat Q1 follow-through and raised outlook.
05-30 01:07
Shares of restaurant and food-related companies are trading higher as oil price declines following reports of a U.S.-Iran peace framework soften the outlook for inflation and boost confidence in consumer spending.
Shares of restaurant and food-related companies are trading higher as oil price...
05-28 00:37
Inside CAVA's Q1 Growth: Increased Foot Traffic And Rapid Expansion
CAVA Group shares are marginally higher Friday as investors lean into the company's upbeat outlook and strong same-store sales momentum.
05-23 00:51
Argus Research Upgrades Cava Group to Buy
Argus Research analyst Christine Dooley upgrades Cava Group (NYSE:CAVA) from Hold to Buy.
05-22 21:35
美股大行评级 | Cava、CrowdStrike、Keysight获多家大行上调目标价；家得宝绩后遭多家大行下调目标价
今日重点评级关注：Oppenheimer：维持Protara Therapeutics"跑赢大市"评级，目标价从25美元升至28美元；Piper Sandler：维持Bright Minds Biosciences"超配"评级，目标价从190美元升至220美元
05-21 12:05
Market-Moving News for May 20th
RBLX: 5% | RBLX stock has given up its prior gain. Roblox shares were trading higher after the company announced a $3 billion repurchase program. CAVA: 8% | CAVA Group shares are trading higher after the
05-20 19:20
财报速睇 | CAVA Group, Inc. 2026财年Q2营收4.38亿美元，同比增长32.1%；归母净利润0.24亿美元，同比下滑8.3%
华盛资讯5月20日讯，CAVA Group, Inc.公布2026财年Q2业绩，公司Q2营收4.38亿美元，同比增长32.1%，归母净利润0.24亿美元，同比下滑8.3%。
05-20 18:17
